A new study published in The Lancet highlights the promising results of a Phase III clinical trial for a live chikungunya vaccine. The vaccine aims to protect individuals...
Kerala has been struck by another viral disease known as the Tomato Flu. It is a rare viral disease due to which blisters shaped like tomatoes are formed....
The Drug Controller General of India (DCGI) has given approval for Phase I and Phase II human clinical trials for COVID-19 vaccine ‘COVAXIN’. In association with the Indian...
From 1st September 2019, Delhi Chief Minister Arvind Kejriwal has decided to launched a mega 10-week anti-mosquito campaign against dengue and chikungunya that aims to increase the participation...
Union Ministry of Health and Family Welfare (MoHFW) have launched a 3 day special campaign called Jan Jagrukta Abhiyaan in New Delhi. It is a campaign aimed towards...
Researchers from Indian Institute of Technology (IIT) Roorkee have identified two small potent molecules Pep-I and Pep-II, for their inhibitory activity to treat Chikungunya disease. The antiviral activity...
The India Meteorological Department (IMD) has announced that it is working on a forecasting system that will give a 15-day warnings on the likelihood of a malaria or...
Outdoor caged trials of genetically modified mosquitoes waere launched in Dawalwadi, Badnapur in Jalna district of Maharashtra to demonstrate the efficiency this technique to suppress wild female mosquito...
Researchers from United States have developed the first vaccine for Chikungunya fever made from an insect-specific Eilat virus. The newly-developed vaccine does not have any side effects on...
